Literature DB >> 10804020

Stimulatory effect of insulin-like growth factor binding protein-5 on mouse osteoclast formation and osteoclastic bone-resorbing activity.

M Kanatani1, T Sugimoto, K Nishiyama, K Chihara.   

Abstract

Insulin-like growth factor binding protein-5 (IGFBP-5) stimulates osteoblast proliferation directly or indirectly through IGF-I action, but its effects on osteoclast formation and osteoclastic activity are unknown. We tested the effects of IGFBP-5 on osteoclastic activity and osteoclast formation. IGFBP-5 significantly stimulated pit formation by pre-existent osteoclasts in mouse bone cell cultures and its stimulatory effect was completely blocked by IGF-I antibody (Ab). However, IGFBP-5 did not affect the bone-resorbing activity of isolated rabbit osteoclasts. When IGFBP-5 was added to unfractionated bone cells after degeneration of pre-existent osteoclasts, IGFBP-5 (77 pM-7.7 nM) dose-dependently stimulated osteoclast-like cell formation, irrespective of the presence of IGF-I Ab. Moreover, osteoclast-like cells newly formed by IGFBP-5 from unfractionated bone cells possessed the ability to form pits on dentine slices. We next examined the direct effect of IGFBP-5 on osteoclast precursors in the absence of stromal cells, using hemopoietic blast cells derived from spleen cells. IGFBP-5 dose-dependently stimulated osteoclast-like cell formation from osteoclast precursors, irrespective of the presence of IGF-I Ab. Growth hormone (GH) as well as IGF-I significantly stimulated bone resorption by pre-existent osteoclasts in mouse bone cell cultures and these stimulatory effects were completely blocked by IGF-I Ab. GH as well as IGF-I stimulated osteoclast-like cell formation from unfractionated bone cells and this stimulatory effect of GH was significantly but partially blocked by IGF-I Ab. The direct stimulatory effect of GH on osteoclast-like cell formation from hemopoietic blast cells was not affected by IGF-I Ab. The present data indicate that IGFBP-5 stimulates bone resorption both by stimulation of osteoclast formation in an IGF-I-independent fashion and by IGF-I-dependent activation of mature osteoclasts, possibly via osteoblasts, in vitro.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10804020     DOI: 10.1359/jbmr.2000.15.5.902

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  10 in total

Review 1.  The multi-functional role of insulin-like growth factor binding proteins in bone.

Authors:  Kristen E Govoni; David J Baylink; Subburaman Mohan
Journal:  Pediatr Nephrol       Date:  2004-11-11       Impact factor: 3.714

2.  A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia.

Authors:  Ninib Baryawno; Dariusz Przybylski; Monika S Kowalczyk; Youmna Kfoury; Nicolas Severe; Karin Gustafsson; Konstantinos D Kokkaliaris; Francois Mercier; Marcin Tabaka; Matan Hofree; Danielle Dionne; Ani Papazian; Dongjun Lee; Orr Ashenberg; Ayshwarya Subramanian; Eeshit Dhaval Vaishnav; Orit Rozenblatt-Rosen; Aviv Regev; David T Scadden
Journal:  Cell       Date:  2019-05-23       Impact factor: 41.582

3.  Amniotic fluid RNA gene expression profiling provides insights into the phenotype of Turner syndrome.

Authors:  Lauren J Massingham; Kirby L Johnson; Thomas M Scholl; Donna K Slonim; Heather C Wick; Diana W Bianchi
Journal:  Hum Genet       Date:  2014-05-22       Impact factor: 4.132

4.  Evidence that IGF-binding protein-5 functions as a growth factor.

Authors:  N Miyakoshi; C Richman; Y Kasukawa; T A Linkhart; D J Baylink; S Mohan
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

5.  Insulin-like growth factor-binding protein-5 induces a gender-related decrease in bone mineral density in transgenic mice.

Authors:  Dervis A M Salih; Subburaman Mohan; Yuji Kasukawa; Gyanendra Tripathi; Fiona A Lovett; Neil F Anderson; Emma J Carter; Jon E Wergedal; David J Baylink; Jennifer M Pell
Journal:  Endocrinology       Date:  2004-11-18       Impact factor: 4.736

Review 6.  Insulin-like growth factor binding protein-5 in osteogenesis: facilitator or inhibitor?

Authors:  Aditi Mukherjee; Peter Rotwein
Journal:  Growth Horm IGF Res       Date:  2007-02-21       Impact factor: 2.372

7.  Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism.

Authors:  Shoshana Yakar; Clifford J Rosen; Mary L Bouxsein; Hui Sun; Wilson Mejia; Yuki Kawashima; Yingjie Wu; Kelly Emerton; Valerie Williams; Karl Jepsen; Mitchell B Schaffler; Robert J Majeska; Oksana Gavrilova; Mariana Gutierrez; David Hwang; Patricia Pennisi; Jan Frystyk; Yves Boisclair; John Pintar; Héctor Jasper; Horacio Domene; Pinchas Cohen; David Clemmons; Derek LeRoith
Journal:  FASEB J       Date:  2008-10-24       Impact factor: 5.191

8.  The fibrotic phenotype induced by IGFBP-5 is regulated by MAPK activation and egr-1-dependent and -independent mechanisms.

Authors:  Hidekata Yasuoka; Eileen Hsu; Ximena D Ruiz; Richard A Steinman; Augustine M K Choi; Carol A Feghali-Bostwick
Journal:  Am J Pathol       Date:  2009-07-23       Impact factor: 4.307

Review 9.  Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis.

Authors:  James Beattie; Gordon J Allan; Jennifer D Lochrie; David J Flint
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

Review 10.  The Role of the Molecular Clock in Skeletal Muscle and What It Is Teaching Us About Muscle-Bone Crosstalk.

Authors:  Lance A Riley; Karyn A Esser
Journal:  Curr Osteoporos Rep       Date:  2017-06       Impact factor: 5.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.